CYTOSTATIC EFFECTS AND MECHANISMS OF ACTION OF BACTERIAL LECTIN OF BACILLUS SUBTILIS IMV B-7724 ON BREAST CANCER CELL LINES OF DIFFERENT MOLECULAR SUBTYPES
DOI:
https://doi.org/10.15407/exp-oncology.2025.03.277Keywords:
lectin, breast cancer, molecular subtypeAbstract
Background. Lectins are carbohydrate-binding proteins with diverse biological activities, and they are increasingly recognized for their potential in cancer diagnostics and therapy. Aim of the study was to investigate the cytostatic and cytotoxic effects of the bacterial lectin of Bacillus subtilis IMV B-7724 on breast cancer (BC) cell lines of different molecular subtypes. Materials and Methods. Experiments were performed on the T47D (luminal A), MCF‑ 7 (luminal B), and MDA-MB-468 (basal, triple-negative) cell lines. Cytotoxicity was assessed by crystal violet staining and LC₅₀/LC₃₀ determination. Cytomorphological alterations were analyzed using the Romanowsky — Giemsa staining and ImageJ morphometry. A flow cytometry was applied to evaluate the cell cycle distribution and apoptosis (Annexin V/PI assay). The expression of proliferation and apoptosis regulators (Ki-67, p53, BCL-2, BAX) was examined by immunocytochemistry. Results. The lectin exerted dose-dependent cytotoxicity across all tested cell lines, with LC₅₀ values ranging between 351—419 μg/mL. The morphological analysis revealed subtype-specific alterations, including cell rounding, nuclear condensation, and decreased cytoplasmic volume, indicative of the apoptotic process. The flow cytometry showed distinct cell cycle arrest patterns: S-phase accumulation in T47D, G2/M blockade in MCF‑ 7, and combined S- and G2/M-phase arrest in MDA-MB-468. The viability assays confirmed a significant reduction of live cells, predominantly through late apoptosis and necrosis, with the strongest effect observed in T47D cells. The immunocytochemistry demonstrated a marked downregulation of Ki-67 and BCL-2, increased p53 expression, and BAX upregulation in MCF‑ 7 cells, whereas T47D cells displayed a paradoxical BAX suppression despite the apoptotic features. Conclusions. Lectin of B. subtilis IMV B-7724 exerts multifaceted effects on BC cells of different molecular subtypes, including the suppression of cell proliferation, activation of apoptosis, and cell cycle modulation. The observed differences between the BC cell lines suggest that the lectin efficacy depends on both the molecular profile of the cells and the mode of apoptosis regulation (p53-dependent or p53-independent), warranting further studies to identify key targets.
References
Barre A, Bourne y, Van damme EJM, Rougé P. Overview of the structure-function relationships of mannose-specific lectins from plants, algae and fungi. Int J Mol Sci. 2019;20(2):254. https://doi.org/10.3390/ijms20020254
Dias Rde O, Machado Ldos S, Migliolo L, franco OL. Insights into animal and plant lectins with antimicrobial activi- ties. Molecules. 2015;20(1):519-541. https://doi.org/10.3390/molecules20010519
Čaval T, Alisson-Silva f, Schwarz f. Roles of glycosylation at the cancer cell surface: opportunities for large scale glycoproteomics. Theranostics. 2023;13(8):2605-2615. https://doi.org/10.7150/thno.81760
Thomas d, Rathinavel AK, Radhakrishnan P. Altered glycosylation in cancer: A promising target for biomarkers and therapeutics. Biochim Biophys Acta Rev Cancer. 2021;1875(1):188464. https://doi.org/10.1016/j.bbcan.2020.188464
Yamashita K, Kuno A, Matsuda A, et al. Lectin microarray technology identifies specific lectins related to lymph node metastasis of advanced gastric cancer. Gastric Cancer. 2016;19(2):531-542. https://doi.org/10.1007/s10120- 015-0491-2
Na h, Liu X, Li X, et al. Novel roles of dC-SIGNR in colon cancer cell adhesion, migration, invasion, and liver metastasis. J Hematol Oncol. 2017;10(1):28. https://doi.org/10.1186/s13045-016-0383-x
Yin S, Li C, Shen X, et al. Siglec-G suppresses Cd8+ T Cells responses through metabolic rewiring and can be targeted to enhance tumor immunotherapy. Adv Sci (Weinh). 2024;11(45):e2403438. https://doi.org/10.1002/ advs.202403438
Rosato f, Pasupuleti R, Tomisch J, et al. A bispecific, crosslinking lectibody activates cytotoxic T cells and induces cancer cell death. J Transl Med. 2022;20(1):578. https://doi.org/10.1186/s12967-022-03794-w
Zhang C, Schumacher KN, dodds Ed, hage dS. Glycoprotein analysis using lectin microcolumns and capillary electrophoresis: сharacterization of alpha1-acid glycoprotein by combined separation methods. J Chromatogr B Analyt Technol Biomed Life Sci. 2021;1179:122855. https://doi.org/10.1016/j.jchromb.2021.122855
Zou X, yoshida M, Nagai-Okatani C, et al. A standardized method for lectin microarray-based tissue glycome mapping. Sci Rep. 2017;7:43560. https://doi.org/10.1038/srep43560
Devi RV, Basil-Rose MR. Lectins as Ligands for directing nanostructured systems. Curr Drug Deliv. 2018;15(4):448- 452. https://doi.org/10.2174/1567201815666180108101246
Meléndez AV, Velasco Cárdenas RM, Lagies S, et al. Novel lectin-based chimeric antigen receptors target Gb3- positive tumour cells. Cell Mol Life Sci. 2022;79(10):513. https://doi.org/10.1007/s00018-022-04524-7
Pasupuleti R, Riedl S, Saltor Núñez L, et al. Lectin-anticancer peptide fusion demonstrates a significant cancer-cell- selective cytotoxic effect and inspires the production of «clickable» anticancer peptide in Escherichia coli. Protein Sci. 2023;32(12):e4830. https://doi.org/10.1002/pro.4830
Kuroda y, Oda T, Shimomura O, et al. Lectin-based phototherapy targeting cell surface glycans for pancreatic can- cer. Int J Cancer. 2023;152(7):1425-1437. https://doi.org/10.1002/ijc.34362
Chekhun Vf, didenko GV, Cheremshenko NL, et al. Strain of bacteria Bacillus subtilis ІMB В-7724 — producer of cytotoxic substances with antitumor activity (Pat. №131824 UA). Publ. 25.01.2019. Bul. №2. fedosova NI, Cherem- shenko NL, hetman KI, et al. Physicochemical and cytotoxicity properties of Bacillus subtilis ІМV В-7724 extracel- lular lectin. Mikrobiol Z. 2021;83:39-48. https://doi.org/10.15407/microbiolj83.01.039
Fedosova NI, Cheremshenko NL, hetman KI, et al. Physicochemical and cytotoxicity properties of Bacillus subtilis
ІМV В-7724 extracellular lectin. Mikrobiol Z. 2021;83:39-48. https://doi.org/10.15407/microbiolj83.01.039
Podgorsky VS. The method for the obtainment of bacterial lectin, specific to sialic acids (Pat. № 1791 UA). Publ. 23.01.1991. Bul. №1.
Chekhun S, Bezdenezhnykh N, Shvets J, Lukianova N. Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype. Exp Oncol. 2013;35(3):174-179.
Chekhun SV, Lukyanova Ny, Shvets yV, et al. Significance of ferritin expression in formation of malignant pheno- type of human breast cancer cells. Exp Oncol. 2014;36(3):179-183.
feoktistova M, Geserick P, Leverkus M. Crystal Violet Assay for determining viability of cultured cells. Cold Spring Harb Protoc. 2016;2016(4):pdb.prot087379. https://doi.org/10.1101/pdb.prot087379
Wittekind dh. On the nature of Romanowsky — Giemsa staining and its significance for cytochemistry and histo- chemistry: an overall view. Histochem J. 1983;15(10):1029-1047. https://doi.org/10.1007/Bf01002498
Lukianova N, Zadvornyi T, Kashuba E, et al. Expression of markers of bone tissue remodeling in breast cancer and prostate cancer cells in vitro. Exp Oncol. 2022;44(1):39-46. https://doi.org/10.32471/exp-oncology.2312-8852.vol- 44-no-1.17354
Chekhun V, Pavlova A, Zadvornyi T, et al. Expression of SPP1 and SPARC genes in tumor tissue of patients with breast cancer. Exp Oncol. 2024;46(1):13-21. https://doi.org/10.15407/exp-oncology.2024.01.013
Hollestelle A, et al. distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines.
Breast Cancer Res Treat. 2010;121(1):53-64. https://doi.org/10.1007/s10549-009-0460-8
Lim Ly, Vidnovic N, Ellisen LW, Leong CO. Mutant p53 mediates survival of breast cancer cells. Br J Cancer. 2009;101(9):1606-1612. https://doi.org/10.1038/sj.bjc.6605335
Stathopoulos GP, Malamos NA, Markopoulos C, et al. The role of Ki-67 in the proliferation and prognosis of breast cancer molecular classification subtypes. Anticancer Drugs. 2014;25(8):950-957. https://doi.org/10.1097/ CAd.0000000000000123
Terävä J, Verhassel A, Botti O, et al. Primary breast cancer biomarkers based on glycosylation and extracellular vesicles detected from human serum. Cancer Rep (Hoboken). 2022;5(8):e1540. https://doi.org/10.1002/cnr2.1540
Lomonosova E, Ryerse J, Chinnadurai G. BAX/BAK-independent mitoptosis during cell death induced by protea- some inhibition? Mol Cancer Res. 2009;7(8):1268-1284. https://doi.org/10.1158/1541-7786.MCR-08-0183
Vousden Kh, Prives C. Blinded by the light: the growing complexity of p53. Cell. 2009;137(3):413-431. https://doi. org/10.1016/j.cell.2009.04.037
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Experimental Oncology

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
